Prulifloxacin

普卢利沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NamePrulifloxacin
Drug Alias NamePrulifloxacine鲁丽沙星Prulifloxacino普芦沙星Prulifloxacinum +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibioticsSmall molecules > Prodrug
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsAcute BronchitisPerianal abscessWounds and Injuries +[27] 
Global Approved IndicationsAcute BronchitisPerianal abscessWounds and Injuries +[25] 
Approved Indications in ChinaUrinary Tract Infections
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesItalyIndia +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAz. Chim. Riun. Angelini Francesco A.C.R.A.F. SpaMeiji Seika Kaisha Ltd
Inactive CompaniesLee'S Pharmaceutical LtdZhaoke Pharmaceutical (Hefei) Co LtdOptimer Pharmaceuticals Llc +[5] 
Active IndicationsAcute BronchitisPerianal abscessPyoderma +[23] 
Inactive IndicationsWounds and InjuriesRespiratory Tract DiseasesGastroenteritis +[4] 

Other Information

ATC CodeJ01MA17
Related LinksWikipediaKEGG